European Journal of Chemistry 2016, 7(1), 97-101. doi:10.5155/eurjchem.7.1.97-101.1358

Development and validation of a stability-indicating RP-LC method for the simultaneous determination of otilonium bromide and its expected degradation product in bulk drug and pharmaceutical preparation


Mohamed Mahmoud El-Kerdawy (1) , Ramzia Ismail El-Bagary (2) , Ehab Farouk Elkady (3) , Ahmed Adel Othman (4,*)

(1) Medicinal Chemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt
(2) Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt
(3) Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt
(4) Central Administration for Pharmaceutical Affairs, Manyal, Cairo 11562, Egypt
(*) Corresponding Author

Received: 06 Nov 2015, Accepted: 29 Nov 2015, Published: 31 Mar 2016

Abstract


A simple, precise, accurate and rapid stability indicating liquid chromatography method had been developed for the simultaneous determination of otilonium bromide (OB) and its expected degradation product; p-aminobenzoic acid (PABA) in bulk powder and pharmaceutical preparation. Chromatographic separation was carried out by isocratic elution on Waters Atlantis C18 column (4.6 × 150 mm, 5 µm) using 2 mM ammonium acetate buffer (pH = 2.35) containing 0.05% TFA: acetonitrile (30:70, v:v) as the mobile phase. The flow rate was 0.8 mL/min with UV detection at 290 nm. Linearity was obtained over a concentration range of 0.5-100 μg/mL with regression coefficient of 1 for OB, and over concentration range of 1-50 μg/mL with regression coefficient of 0.9998 for PABA. The values of LOD and LOQ were found to be 0.0665 and 0.2018 μg/mL for OB and 0.1974 and 0.598 μg/mL for PABA, respectively. The method was validated as per ICH guidelines. The method was successfully applied to the determination of the drug in bulk powder and pharmaceutical preparation.


Keywords


RP-LC; Otilonium bromide; p-Aminobenzoic acid; Stability indicating assay; Pharmaceutical preparation; Simultaneous determination

Full Text:

PDF /    /


DOI: 10.5155/eurjchem.7.1.97-101.1358

Article Metrics


This Abstract was viewed 563 times | PDF Article downloaded 238 times

References

[1]. Poynard, T.; Regimbeau, C.; Benhamou, Y. Aliment. Pharm. Ther. 2001, 15(3), 355-361.
http://dx.doi.org/10.1046/j.1365-2036.2001.00937.x

[2]. Spinelli, A. Clin. Drug Invest. 2007, 27(1), 15-33.
http://dx.doi.org/10.2165/00044011-200727010-00002

[3]. Lesbros-Pantoflickova, D.; Michetti, P.; Fried, M.; Beglinger, C. Blum, A. L. Aliment. Pharm. Ther. 2004, 20(11-12), 1253-1269.
http://dx.doi.org/10.1111/j.1365-2036.2004.02267.x

[4]. Signorini, C.; Tosoni, S.; Ballerini, R.; Chinol, M.; Mannucci, C. Drug. Exp. Clin. Res. 1984, 10, 273-276.

[5]. Sutton, J. A.; Kilminster, S. G.; Mould, G. P. Eur. J. Clin. Pharmacol. 1997, 52(5), 365-369.
http://dx.doi.org/10.1007/s002280050302

[6]. Zhao, Y. R.; Ding, Li; Fan, H. W.; Yu, Y.; Qi, X. M.; Leng, Y.; Rao, Y. K. J. Chromatogr. B 2010, 878(28), 2896-2900.
http://dx.doi.org/10.1016/j.jchromb.2010.08.003

[7]. Evangelista, S.; Cochet, P.; Bromet, N.; Criscuoli, M.; Maggi, C. A. Drug. Metab. Dispos. 2000, 28(6), 643-647.

[8]. Bonanni, R.; Morocutti, A.; Nuti, A.; Pannini, S.; Mittica, V. Farmacia 1981, 6-7, 421-426.

[9]. Mannucci, C.; Bertini, J.; Cocchini, A.; Perico, A.; Salvagnini, F.; Triolo, A. J. Pharm. Sci. 1993, 82(4), 367- 370.
http://dx.doi.org/10.1002/jps.2600820406

[10]. Santoni, G.; Fabbri, L.; Mura, P.; Renzi, G.; Gratteri, P.; Pinzauti, S. Int. J. Pharm. 1991, 71(1-2), 1-5.
http://dx.doi.org/10.1016/0378-5173(91)90061-R

[11]. Kibum, K.; Haehum, J.; Hyi-Yoel, Y.; Seung-Ok, M.; Young-Ran, Y.; Kwang-il, K.; Hyesoo, K.; Soojung, S.; Wonku, K. Chromatographia 2007, 66(3-4), 257-260.
http://dx.doi.org/10.1365/s10337-007-0274-y

[12]. Shin, B. S.; Kim, J. J.; Kim. J.; Hu, S. K; Kim, H. K.; Lee, H. S.; Yoo, S. D. Arch. Pharm. Res. 2008, 31(1), 117-124.
http://dx.doi.org/10.1007/s12272-008-1129-2

[13]. Furlanetto, S.; Orlandini, S.; Massolini, G.; Faucci, M. T.; La Porta, E.; Pinzauti, S. Analyst 2001, 126(10), 1700-1706.
http://dx.doi.org/10.1039/b103091b

[14]. Morelli, B. Fresen. J. Anal. Chem. 1997, 357, 1179-1184.
http://dx.doi.org/10.1007/s002160050327

[15]. Mannucci, C.; Bertini, J.; Cocchini, A.; Perico, A.; Salvagnini, F.; Triolo, A. J. Pharm. Sci. 1992, 81(12), 1175-1177.
http://dx.doi.org/10.1002/jps.2600811209

[16]. El-Kousy, N. M.; Bebawy, L. I. J. AOAC Int. 1999, 82(3), 599-606.

[17]. Blanco, M.; Coello, J.; Iturriaga, H.; Maspoch, S.; Pou, N. Fresen. J. Anal. Chem. 2000, 368, 534-539.
http://dx.doi.org/10.1007/s002160000506

[18]. Zhao, Y; Ding, L.; Rao, Y.; Tang, X.; Ding, J. J. China Pharm. Univ. 2010, 41(6), 548-554.

[19]. De Ruiter, J. Amides and Related Functional Groups. In: Principles of Drug Action 1, Spring, 2005.

[20]. Snyder, L.; Kirkland, J. and Glajch, J. Ed.; Wiley- Interscience New York, Chichester, Brisbane, Toronto, Singapore, 1988.

[21]. ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology, Q2(R1), Current Step 4 Version, Parent Guidelines on Methodology Dated November 6 1996, Incorporated in November 2005.


How to cite


El-Kerdawy, M.; El-Bagary, R.; Elkady, E.; Othman, A. Eur. J. Chem. 2016, 7(1), 97-101. doi:10.5155/eurjchem.7.1.97-101.1358
El-Kerdawy, M.; El-Bagary, R.; Elkady, E.; Othman, A. Development and validation of a stability-indicating RP-LC method for the simultaneous determination of otilonium bromide and its expected degradation product in bulk drug and pharmaceutical preparation. Eur. J. Chem. 2016, 7(1), 97-101. doi:10.5155/eurjchem.7.1.97-101.1358
El-Kerdawy, M., El-Bagary, R., Elkady, E., & Othman, A. (2016). Development and validation of a stability-indicating RP-LC method for the simultaneous determination of otilonium bromide and its expected degradation product in bulk drug and pharmaceutical preparation. European Journal of Chemistry, 7(1), 97-101. doi:10.5155/eurjchem.7.1.97-101.1358
El-Kerdawy, Mohamed, Ramzia Ismail El-Bagary, Ehab Farouk Elkady, & Ahmed Adel Othman. "Development and validation of a stability-indicating RP-LC method for the simultaneous determination of otilonium bromide and its expected degradation product in bulk drug and pharmaceutical preparation." European Journal of Chemistry [Online], 7.1 (2016): 97-101. Web. 21 Sep. 2019
El-Kerdawy, Mohamed, El-Bagary, Ramzia, Elkady, Ehab, AND Othman, Ahmed. "Development and validation of a stability-indicating RP-LC method for the simultaneous determination of otilonium bromide and its expected degradation product in bulk drug and pharmaceutical preparation" European Journal of Chemistry [Online], Volume 7 Number 1 (31 March 2016)

DOI Link: https://doi.org/10.5155/eurjchem.7.1.97-101.1358

Refbacks

  • There are currently no refbacks.




Copyright (c)




© Copyright 2019  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2019 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 4614 Lavista road, Tucker, GA, 30084, USA. Registered in USA.